We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Wearable Sensing Patch Enables Rapid Quantitative Analysis of Urea in Body Fluids

By LabMedica International staff writers
Posted on 24 Feb 2023

Urea, which is excreted in sweat, urine, saliva and blood, is a key indicator of renal function in clinical diagnosis. More...

Effective determination of urea levels can enable early detection of diseases. There has been growing focus on wearable fluorescence-based sensors, although traditional fluorescent hydrogels are excited by short wavelengths, hampering the detection of biological samples. Now, researchers have developed a wearable sensing patch that enables the rapid quantitative analysis of urea.

Spontaneous and background fluorescence can interfere with the detection of biological samples. Upconversion nanoparticles (UCNPs), which can eliminate the self-fluorescence and background interference of biological samples, are an effective strategy for detecting human biomarkers with high sensitivity. Researchers from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences (Beijing, China) have developed a polyacrylamide (PAM) hydrogel sensor based on an upconversion optical probe, which was composed of UCNPs and p-dimethylamino-cinnamaldehyde (p-DMAC). As a result of the internal filtration effect, the red product produced by the reaction of urea and p-DMAC quenched the green fluorescence of the UCNPs and caused the upconversion fluorescence to change from yellow to red, thus realizing the fluorescence detection of urea.

Based on this, the researchers fabricated a flexible wearable sensor by combining PAM hydrogel and a portable sensor platform built using 3D printing technology. The researchers found the limits of detection of the self-designed upconversion fluorescent probe and the hydrogel sensor to be just 1.4 μM and 30 μM, respectively, which was much lower than the urea content in sweat, implying higher sensitivity. The sensor patch design paves the way for a convenient approach to accurately detect biomarkers in body fluids and for development into a device that could provide disease warning and clinical diagnosis, according to the researchers.

Related Links:
Chinese Academy of Sciences


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.